[Available for Review]
H-index: 57
Manuscripts in Review: 0
Reviewed Articles: 0
Invitation Reply Cycle: 24 h
Total Points: 20
Manuscript Review Cycle: 4 days
Country: United States
Institution: Genesis Biotechnology Group LLC
Section: Pharmacology & Toxicology
Keywords: Immunotoxicity,Genotoxicity,cytotoxicity,carcinogenesis,cell signaling,signal transduction,Mechanism of action,Therapeutics,therapeutic targets,biomarkers,prognostic,diagnostic markers,immunology,inflammation,lung inflammation,Pulmonary cardiovascular,placental pathologies,BPD,PAH,Lung Fibrosis,IBD,Psoriasis,neurodegenrative diseases,murine models of disease,assay development,invitro assays,invivo murine models,colon cancer,Lung cancer,syngeneic models,xenograft models,orthotopic models,ADME/PK/PD,drug toxicity and efficacy,Preclinical drug development
Representative Publications
--
Review journals:
No data.
Feeling limited by your filters? Break free and rediscover!
All Reviewers